Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury

Stem Cells and Development

Volumn 21, Issue 16, 2012, Pages 2969-2980

  Gheisari, Yousof ^a,b   Azadmanesh, Kayhan ^a   Ahmadbeigi, Naser ^b   Nassiri, Seyed Mahdi ^c   Golestaneh, Azadeh Fahim ^b   Naderi, Mahmood ^b,d   Vasei, Mohammad ^e   Arefian, Ehsan ^b   Mirab Samiee, Siamak ^f,g   Shafiee, Abbas ^b   Soleimani, Masoud ^d   Zeinali, Sirous ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^g Day General Hospital Laboratory   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CISPLATIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; STROMAL CELL DERIVED FACTOR 1;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; DNA MODIFICATION; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RENAL PROTECTION; STEM CELL EXPANSION; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL MOVEMENT; CELL SEPARATION; CISPLATIN; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENETIC THERAPY; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, CXCR; RECEPTORS, CXCR4; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 84867784131     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0588     Document Type: Article

References (59)

1. LiPK, JJWeening, JDirks, SL Lui,CCSzeto, S Tang, RCAtkins, WE Mitch, KM Chow, et al. (2005). A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. Kidney Int Suppl:S2YS7.
2. Meguid El Nahas A and AK Bello. (2005). Chronic kidney disease: The global challenge. Lancet 365:331-340.
3. Perico N, A Benigni and G Remuzzi. (2008). Present and future drug treatments for chronic kidney diseases: Evolving targets in renoprotection. Nat Rev Drug Discov 7:936-953.
4. Herrera MB, B Bussolati, S Bruno, V Fonsato, GM Romanazzi and G Camussi. (2004). Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14:1035-1041.
5. Lin F, K Cordes, L Li, L Hood, WG Couser, SJ Shankland and P Igarashi. (2003). Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemiareperfusion injury in mice. J Am Soc Nephrol 14:1188-1199.
6. Morigi M, B Imberti, C Zoja, D Corna, S Tomasoni, M Abbate, D Rottoli, S Angioletti, A Benigni, et al. (2004). Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794-1804.
7. Guillot PV, HT Cook, CD Pusey, NM Fisk, S Harten, J Moss, I Shore and G Bou-Gharios. (2008). Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol 214:627-636.
8. Lazzeri E, C Crescioli, E Ronconi, BMazzinghi, C Sagrinati, GS Netti, ML Angelotti, E Parente, L Ballerini, et al. (2007). Regenerative potential of embryonic renalmultipotent progenitors in acute renal failure. J Am Soc Nephrol 18:3128-3138.
9. Gheisari Y, SM Nassiri, E Arefian, N Ahmadbeigi, K Azadmanesh, M Jamali, I Jahanzad, S Zeinali, M Vasei and M Soleimani. (2010). Severely damaged kidneys possess multipotent renoprotective stem cells. Cytotherapy 12:303-312.
10. Kale S, A Karihaloo, PR Clark, M Kashgarian, DS Krause and LG Cantley. (2003). Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112:42-49.
11. Duffield JS, KM Park, LL Hsiao, VR Kelley, DT Scadden, T Ichimura and JV Bonventre. (2005). Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755.
12. Krause D and LG Cantley. (2005). Bone marrow plasticity revisited: protection or differentiation in the kidney tubule? J Clin Invest 115:1705-1708.
13. Togel F, Z Hu, K Weiss, J Isaac, C Lange and C Westenfelder. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31YF42.
14. Bi B, R Schmitt, M Israilova, H Nishio and LG Cantley. (2007). Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-2496.
15. Duffield JS and JV Bonventre. (2005). Kidney tubular epithelium is restored without replacement with bone marrowderived cells during repair after ischemic injury. Kidney Int 68:1956-1961.
16. Burst VR, M Gillis, F Putsch, R Herzog, JH Fischer, P Heid, J Muller-Ehmsen, K Schenk, JW Fries, CA Baldamus and T Benzing. (2010). Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol 114:e107Ye116.
17. Kollet O, S Shivtiel, YQ Chen, J Suriawinata, SN Thung, MD Dabeva, J Kahn, A Spiegel, A Dar, et al. (2003). HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34 + stem cell recruitment to the liver. J Clin Invest 112:160-169.
18. Ponomaryov T, A Peled, I Petit, RS Taichman, L Habler, J Sandbank, F Arenzana-Seisdedos, A Magerus, A Caruz, et al. (2000). Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 106:1331-1339.
19. Wojakowski W, M Tendera, A Michalowska, M Majka, M Kucia, K Maslankiewicz, R Wyderka, A Ochala and MZ Ratajczak. (2004). Mobilization of CD34/CXCR4 +, CD34/CD117 +, c-met + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110:3213-3220.
20. Ahmadbeigi N, E Seyedjafari, Y Gheisari, A Atashi, A Omidkhoda and M Soleimani. (2010). Surface expression of CXCR4 in unrestricted somatic stem cells and its regulation by growth factors. Cell Biol Int 34:687-692.
21. Honczarenko M, Y Le, M Swierkowski, I Ghiran, AM Glodek and LE Silberstein. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-1041.
22. Brenner S, N Whiting-Theobald, T Kawai, GF Linton, AG Rudikoff, U Choi, MF Ryser, PM Murphy, JM Sechler and HL Malech. (2004). CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells 22:1128-1133.
23. Kahn J, T Byk, L Jansson-Sjostrand, I Petit, S Shivtiel, A Nagler, I Hardan, V Deutsch, Z Gazit, et al. (2004). Overexpression of CXCR4 on human CD34 + progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 103:2942-2949.
24. Abbott JD, Y Huang, D Liu, R Hickey, DS Krause and FJ Giordano. (2004). Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300-3305.
25. Aiuti A, IJ Webb, C Bleul, T Springer and JC Gutierrez-Ramos. (1997). The chemokine SDF-1 is a chemoattractant for human CD34 + hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185:111-120.
26. Askari AT, S Unzek, ZB Popovic, CK Goldman, F Forudi, M Kiedrowski, A Rovner, SG Ellis, JD Thomas, et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-703.
27. Kortesidis A, A Zannettino, S Isenmann, S Shi, T Lapidot and S Gronthos. (2005). Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105:3793-3801.
28. Levoye A, K Balabanian, F Baleux, F Bachelerie and B Lagane. (2009). CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113:6085-6093.
29. Sierro F, C Biben, L Martinez-Munoz, M Mellado, RM Ransohoff, M Li, B Woehl, H Leung, J Groom, et al. (2007). Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A 104:14759-14764.
30. Mazzinghi B, E Ronconi, E Lazzeri, C Sagrinati, L Ballerini, ML Angelotti, E Parente, R Mancina, GS Netti, et al. (2008). Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 205:479-490.
31. Dobson KR, L Reading, M Haberey, X Marine and A Scutt. (1999). Centrifugal isolation of bone marrow from bone: An improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int 65:411-413.
32. Peister A, JA Mellad, BL Larson, BM Hall, LF Gibson and DJ Prockop. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668.
33. Naldini L, U Blomer, P Gallay, D Ory, R Mulligan, FH Gage, IM Verma and D Trono. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
34. Chatterjee PK, PA Brown, S Cuzzocrea, K Zacharowski, KN Stewart, H Mota-Filipe, MC McDonald and C Thiemermann. (2001). Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int 59: 2073-2083.
35. Faubel S, EC Lewis, L Reznikov, D Ljubanovic, TS Hoke, H Somerset, DJ Oh, L Lu, CL Klein, CA Dinarello and CL Edelstein. (2007). Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 322:8-15.
36. Castellani S and PM Adams. (1981). Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol 73:143-154.
37. Alexandre CS, RA Volpini, MH Shimizu, TR Sanches, P Semedo, VL di Jura, NO Camara, AC Seguro and L Andrade. (2009). Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells 27:682-692.
38. Kyriakou C, N Rabin, A Pizzey, A Nathwani and K Yong. (2008). Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 93:1457-1465.
39. Baddoo M, K Hill, R Wilkinson, D Gaupp, C Hughes, GC Kopen and DG Phinney. (2003). Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89:1235-1249.
40. Meirelles Lda S and NB Nardi. (2003). Murine marrowderived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123:702-711.
41. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
42. Togel F, A Cohen, P Zhang, Y Yang, Z Hu and C Westenfelder. (2009). Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 18:475-485.
43. Gheisari Y, M Soleimani, K Azadmanesh and S Zeinali. (2008). Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy 10:815-823.
44. Wagstaff MJ, CE Lilley, J Smith, MJ Robinson, RS Coffin and DS Latchman. (1998). Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo. Gene Ther 5:1566-1570.
45. Lee RH, AA Pulin, MJ Seo, DJ Kota, J Ylostalo, BL Larson, L Semprun-Prieto, P Delafontaine and DJ Prockop. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63.
46. Stokman G, I Stroo, N Claessen, GJ Teske, S Florquin and JC Leemans. (2010). SDF-1 provides morphological and functional protection against renal ischaemia/reperfusion injury. Nephrol Dial Transplant 25:3852-3859.
47. Stroo I, G Stokman, GJ Teske, S Florquin and JC Leemans. (2009). Haematopoietic stem cell migration to the ischemic damaged kidney is not altered by manipulating the SDF-1/CXCR4-axis. Nephrol Dial Transplant 24:2082-2088.
48. Togel F, J Isaac, Z Hu, K Weiss and C Westenfelder. (2005). Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 67:1772-1784.
49. Bonig H, GV Priestley and T Papayannopoulou. (2006). Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. Blood 107:79-86.
50. Lee RH, JM Song, MY Park, SK Kang, YK Kim and JS Jung. (2001). Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 62:1013-1023.
51. Lieberthal W, V Triaca and J Levine. (1996). Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis. Am J Physiol 270:F700YF708.
52. Behr L, M Hekmati, A Lucchini, K Houcinet, AM Faussat, N Borenstein, LH Noel, M Lelievre-Pegorier and K Laborde. (2009). Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury. Cell Prolif 42:284-297.
53. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067.
54. Kunter U, S Rong, Z Djuric, P Boor, G Muller-Newen, D Yu and J Floege. (2006). Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17:2202-2212.
55. Semedo P, PM Wang, TH Andreucci, MA Cenedeze, VP Teixeira, MA Reis, A Pacheco-Silva and NO Camara. (2007). Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant Proc 39:421-423.
56. Aguilar S, E Nye, J Chan, M Loebinger, B Spencer-Dene, N Fisk, G Stamp, D Bonnet and SM Janes. (2007). Murine but not human mesenchymal stem cells generate osteosarcomalike lesions in the lung. Stem Cells 25:1586-1594.
57. Ahmadbeigi N, M Soleimani, Y Gheisari, M Vasei, S Amanpour, I Bagherizadeh, SA Shariati, K Azadmanesh, S Amini, et al. (2011). Dormant phase and multinuclear cells: Two key phenomena in early culture of murine bone marrow mesenchymal stem cells. Stem Cells Dev 20:1337-1347.
58. Miura M, Y Miura, HM Padilla-Nash, AA Molinolo, B Fu, V Patel, BM Seo, W Sonoyama, JJ Zheng, et al. (2006). Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24:1095-1103.
59. Zhou YF, M Bosch-Marce, H Okuyama, B Krishnamachary, H Kimura, L Zhang, DL Huso and GL Semenza. (2006). Spontaneous transformation of cultured mouse bone marrowderived stromal cells. Cancer Res 66:10849-10854.